Osarumen Okunbor, MD
Vascular Surgery · Covington, LANPI 1891108700
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (52.2%), food and beverage and grants — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Medtronic at 40.9% of the total. Among vascular surgery clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 232 payments — averaging $163.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$16K
- Abbott$4K
- Penumbra, Inc.$3K
- Philips North America LLC$2K
- Boston Scientific$2K
- VB Spine LLC$2K
- plus $9K from 22 others
What the payments were for
- Grants$8,00021%
- Travel & lodging$19,85152%
- Food & beverage$10,14927%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 65 | $15,547 |
| Abbott | 20 | $4,159 |
| Penumbra, Inc. | 17 | $2,961 |
| Philips North America LLC | 22 | $2,464 |
| Boston Scientific | 22 | $2,335 |
| VB Spine LLC | 16 | $1,888 |
| Silk Road Medical, Inc. | 11 | $1,781 |
| Lemaitre Vascular, Inc. | 7 | $1,697 |
| Cook Incorporated | 3 | $1,069 |
| Cardiovascular Systems Inc. | 5 | $807 |
| Globus Medical | 4 | $746 |
| W. L. Gore & Associates, Inc. | 6 | $630 |
| Cook Medical LLC | 7 | $622 |
| Shockwave Medical, Inc | 6 | $432 |
| Endologix LLC | 3 | $349 |
| Inari Medical, Inc. | 1 | $142 |
| Vantive US Healthcare LLC | 1 | $73 |
| Bard Peripheral Vascular, Inc. | 3 | $56 |
| Tactile Systems Technology Inc | 2 | $52 |
| Surmodics, Inc. | 2 | $41 |
| Corcept Therapeutics | 2 | $39 |
| Angiodynamics, Inc. | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Pfizer | 1 | $17 |
| Mozarc Medical US LLC | 1 | $16 |
| Smith+Nephew | 1 | $15 |
| Terumo Medical Corporation | 1 | $14 |
| Integra Lifesciences Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Endurant$8,534
- TurboHawk$3,137
- Indigo System$2,688
- Diamondback Peripheral$2,360
- (9520) IGT Devices Undivided$2,005
- ENROUTE Transcarotid Neuroprotection System$1,916
- OMNILINK ELITE$1,888
- VenaSeal$1,699
- STRYKER$1,686
- ENROUTE Transcarotid Stent$1,656
- HYDRO LEMAITRE VALVULOTOME$1,593
- Micropuncture$932
- JETSTREAM SC$854
- HawkOne$491
- ExcelsiusGPS Robotic Navigation System$472
- ELUVIA$418
- Zilver PTX$318
- GENERAL VASCULAR INTERVENTION$289
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$271
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$265
How this compares
$37,999 in reported general payments places this provider in the 90th percentile of 65 vascular surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 23 | $17,694 |
| XareltoRivaroxaban | 12 | $7,499 |
| ClopidogrelClopidogrel Bisulfate | 82 | $517 |
| Mupirocin | 65 | $499 |
| Chlorhexidine Gluconate | 66 | $273 |
| Oxycodone Hcl | 59 | $229 |
| Tramadol Hcl | 18 | $43 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $17 | $17,69423 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 65 vascular surgery providers in Louisiana.
Other vascular surgery in Covington
- Asha KhachaneCovington$4K
- Ali KhoobehiCovington$4K
- Philip GardnerCovington$3K
- Michael Conners IiiBaton Rouge$70K
- Gregory CrenshawMetairie$67K
- James CravenBaton Rouge$65K
- Marvin WeaverBaton Rouge$58K
- Christopher LagraizeLafayette$47K
- Paul PerkowskiShreveport$41K
- Malachi SheahanMarrero$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.